1-6 of 6
Dongmei Yan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Combined Anti-PD-1, Bortezomib and Pegaspargase Regimen for Newly Diagnosed Early Stage Extranodal NK/T-Cell Lymphoma

Xiangmin Wang, Qing Zhang, Yujie Li, Ruiyang Xie, Hongyuan Zhou, Xicheng Chen, Linyan Xu, Jianlin Qiao, Dongmei Yan, Kailin Xu, Wei Sang
Journal: Blood
Blood (2024) 144 (Supplement 1): 6412.
https://doi.org/10.1182/blood-2024-207344
Published: 2024
Journal Articles

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: An Updated Report on the Pivotal Study of Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-Cell ALL) in China

Wang Ying, Lulu Lv, Yongping Song, Xudong Wei, Hongsheng Zhou, Qifa Liu, Kailin Xu, Dongmei Yan, Cheng Zhang, Shuangyou Liu, Jie Jin, Heng Mei, Ting Niu, Aibin Liang, Runxia Gu, Chunmei Zheng, Yi Feng, Wenqiu Huang, Shuai Xin, Wei Jin, Lin Shi, Yongzeng Wang, Jianxiang Wang
Journal: Blood
Blood (2024) 144 (Supplement 1): 4196.
https://doi.org/10.1182/blood-2024-199983
Published: 2024
Journal Articles

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China

Ying Wang, Xudong Wei, Dongmei Yan, Cheng Zhang, Hongsheng Zhou, Chunrong Tong, Heng Mei, Jie Jin, Ting Niu, Aibin Liang, Jienan Ren, Yiping Deng, Wei Jin, Yi Feng, Lin Shi, Yongzeng Wang, Changting Haudenschild, Lulu Lv, Jianxiang Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 1598–1600.
https://doi.org/10.1182/blood-2022-165002
Published: 2022
Journal Articles

Gls-010, a Novel Anti-PD-1 Mab in Chinese Patients with Relapsed or Refractory Classical Hodgkin Lymphoma: Preliminary Impressive Results of a Phase II Clinical Trial

Yuqin Song, MD PhD, Jun Zhu, BS, Ningjing Lin, MD PhD, Mingzhi Zhang, MD, Hai Bai, MD, Hui Liu, MD, Jie Cui, MD, Xiaoyan Ke, MD, Huilai Zhang, MD PhD, Lihong Liu, MD, Dongmei Yan, MD, Yongsheng Jiang, MD, Aimin Zang, MD, Junyuan Qi, MD, Li Wang, MD, Zhuogang Liu, MD, Bing Xu, MD PhD, Ying Zhang, MD, Zhihui Zhang, MD PhD, Haijin Meng, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17.
https://doi.org/10.1182/blood-2020-136475
Published: 2020
Journal Articles

EHMT2 Inhibitor BIX-01294 Induces Endoplasmic Reticulum Stress Mediated Apoptosis and Autophagy in Diffuse Large B Cell Lymphoma Cells

Linyan Xu, PhD, Xiang Gao, Wei Sang, MD, Dongmei Yan, Xuguang Song, Feng Zhu, Kailin Xu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2787.
https://doi.org/10.1182/blood-2019-127653
Published: 2019
Journal Articles

Combination of Anti-CD19 and Anti-CD20 Chimeric Antigen Receptor T Cells for Relapsed and Refractory Diffuse Larger B Cell Lymphoma: An Open-Label, Single-Arm, Phase Ⅰ/Ⅱ Trial

Wei Sang, MD, Ming Shi, Jingjing Yang, Jiang Cao, MD, Linyan Xu, PhD, Dongmei Yan, Xuguang Song, Cai Sun, Depeng Li, Feng Zhu, Zhenyu Li, MD, Junnian Zheng, Jianlin Qiao, PhD, Kailin Xu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1590.
https://doi.org/10.1182/blood-2019-127640
Published: 2019